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Abstract
Background: Radiation therapy is performed as an adjuvant therapy when indicated following surgical resection
of malignant tumors. However, radiation exposure induces acute or chronic dermatitis, depending on the
radiation dose, interval, tissue volume, or irradiated area of the body. Radiation-induced skin ulcers and
osteomyelitis of the underlying bone are intractable late-stage complications of radiation therapy, and often
require reconstructive surgery to cover exposed tissue. Hyperbaric oxygen therapy has been suggested as a
treatment for delayed radiation injury with soft tissue and bony necrosis.
Case presentation: A 74-year-old Japanese female underwent left radical mastectomy for breast cancer
(T3N3M0, stage IIIB) in 1987. Radiation therapy was initiated 6 weeks after the surgery. She received
telecobalt-60 in a total dose of 50 Gy with 25 fractions to the left supraclavicular, parasternal and left axillary
regions, and electron treatment (9 MeV) in a total dose of 50 Gy in 25 fractions to the left chest wall. After
irradiation, her skin became thinner and more fragile on the left chest wall, but no severe infections were
observed. She noticed a small ulcer that repeatedly healed and recurred in 2000. She visited the hospital
where she received radiation therapy and was treated for a skin ulcer on the left chest wall in December
2012. A fistula developed and then pus was discharged in January 2013. She was referred to the hyperbaric
medical center in February 2013, and the fistula (1.5 × 3 cm) with pus discharge was observed. She was
diagnosed with a late-onset radiation-induced skin ulcer that developed 25 years after radical mastectomy.
HBO2 (2.5 atmospheres absolute with 100% oxygen for 60 minutes) was indicated for the refractory ulcer and
osteomyelitis of the ribs. The patient was treated with HBO2 a total of 101 times over the course of 1 year
and completely recovered.
Conclusions: Hyperbaric oxygen therapy can be performed safely for even more than 100 sessions in
patients with radiation-induced skin ulcers and osteomyelitis. Hyperbaric oxygen therapy can be considered
as an alternative, conservative treatment when surgical resection for late-onset, radiation-induced skin ulcers
is not indicated because of fragile skin in the irradiated areas.
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Background
Recently, the use of fluoroscopic procedures has in-
creased as a result of advances in interventional radi-
ology such as cardiac catheterization or intravascular
surgery, which use such procedures. However, radiation
exposure can cause dermopathies, including refractory
skin ulcers [1]. Guidelines for radiation exposure were
established by the Society of Interventional Radiology in
2009 [2]. Japanese guidelines were also established by
the Japanese Society for Therapeutic Radiology and
Oncology in 2012 (http://www.jastro.or.jp/guideline/
child.php?eid=00007). Radiation therapy is widely recog-
nized as a curative treatment for multiple types of can-
cers, including prostate, head and neck, lung, uterine,
esophageal, and brain cancers, as well as lymphomas. In
breast cancer, radiation therapy is used primarily as an
adjuvant treatment following surgery [3]. However, high-
dose radiation exposure of thin soft tissue often causes
acute or delayed skin ulcers. In addition, osteomyelitis of
the ribs becomes intractable when chest skin ulcers are
present. In such cases, chest wall reconstruction might
finally be needed in addition to aggressive skin or rib
resection [4].
Hyperbaric oxygen therapy (HBO2) has been suggested
for treatment of delayed radiation injury with soft tissue
and bony necrosis [5]. We report a case of a patient with
refractory skin ulcer of the left chest wall that developed
after radical mastectomy and radiation therapy for breast
cancer, which was successfully treated with HBO2.
Case presentation
A 74-year-old Japanese woman underwent left radical
mastectomy in 1987 for breast cancer with a size of 6 ×
4 cm in the upper outer quadrant (T3N3M0, stage IIIB).
Tamoxifen was administered in addition to tegafur and
OK-432 as an adjuvant chemotherapy after the surgery.
The tumor was negative for both estrogen receptor and
progesterone receptor and was evaluated as N2b. Radi-
ation therapy was initiated 6 weeks after the surgery.
Initially, the patient received telecobalt-60 treatment,
comprising 24 Gy in 12 fractions (days) to the supracla-
vicular and parasternal regions and 14 Gy in 7 fractions
(days) to the left axilla, because of delayed wound heal-
ing after the surgery. Her wound was completely healed
15 days after the radiation treatment. The cobalt-60
treatment was resumed, comprising 26 Gy in 13 frac-
tions to the supraclavicular and parasternal regions and
36 Gy in 18 fractions to the left axilla for 27 days, result-
ing in a total of 50 Gy in 25 fractions in each region. At
the same time, electron treatment (9 MeV) to the left
chest wall was started such that it did not overlap with
the treatment of the supraclavicular, parasternal, and ax-
illary regions. After the patient had received 44 Gy in 22
fractions at 32 days, skin redness and swelling occurred,
and the treatment was stopped. After a 1-month rest
period, 3 additional fractions were performed to provide
a total of 50 Gy in 25 fractions. At that time, a keloidal
change corresponding to the electron treatment area on
the patient’s left chest wall was noted; her skin became
thinner and more fragile, but no severe infections were
observed.
The patient noticed a small ulcer at the beginning of
2000, but the ulcer healed over time without treatment.
She visited the hospital where she received radiation
therapy in December 2012, and at that time she was
treated with cadexomer iodine ointment for a skin ulcer
on the left chest wall. A fistula eventually developed, and
pus discharging from the fistula was observed in January
2013. She was referred to the hyperbaric medical center
in February 2013. The fistula (1.5 × 3 cm) with pus dis-
charge on her left chest wall was noted at her first visit
(Fig. 1a). The skin around the lesion showed redness and
swelling with a keloidal change. The pus discharge was
synchronized to her respiratory rhythm, and a bacterial
identification test result was positive for Staphylococ-
cus aureus. A pulmonary function test revealed pul-
monary restriction (percent predicted vital capacity
[%VC] 60.6 %, percent predicted forced expiratory
volume in 1 second [FEV1%] 80.2 %). Chest radiog-
raphy showed cardiac enlargement. Chest computed
tomography (CT) showed no cystic lesions, and the
fistula located on the left chest wall did not invade
the thorax (Fig. 1b). The patient was diagnosed with
a late-onset, radiation-induced skin ulcer that devel-
oped 25 years after radical mastectomy. HBO2 was in-
dicated for the refractory ulcer and osteomyelitis of
the ribs. Her medical history included acute myocardial
infarction and a stent implanted in 2003. She was
instructed to communicate any problems including otal-
gia, ear fullness, hearing loss, tinnitus, vertigo, and dizzi-
ness to a physician at the hyperbaric medical center.
HBO2 therapy was started in March 2013 after written
informed consent was obtained. A multiplace hyperbaric
chamber (NHC-412-A; Nakamura Tekko-Sho K.K.,
Tokyo, Japan) was pressurized up to 2.5 atmospheres ab-
solute (ATA) with 100 % oxygen delivered through a
mask. The duration of each treatment session was 105
minutes, including 15 minutes of compression at the be-
ginning and 20 minutes of decompression at the end of
treatment. The patient tolerated the HBO2 protocol
without any adverse effects, despite her pulmonary re-
striction and cardiac enlargement. After 25 sessions over
the course of 3 months, granulation tissue was observed
around the margin of the ulcer, but massive pus dis-
charge was still noted (Fig. 2a). At this time, a physician
suggested that the ulcer be washed with tap water once
daily. Granulation tissue gradually increased and pus dis-
charge diminished without use of antibiotics (Fig. 2b, c).
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After 86 sessions over the course of 11 months, epitheli-
alization was observed and pus discharge disappeared
(Fig. 2d). A pulmonary function test at this time still re-
vealed pulmonary restriction (%VC 58.6 %, FEV1% 85.2
%), with no remarkable change compared with previous
findings. After 101 sessions over a period of 1 year, the
ulcer was considered to be healed. The patient no longer
had to cover her skin wound and was able to bathe after
the treatment. At a follow-up visit 6 months after the
completion of HBO2 therapy, no recurrence of skin ul-
ceration was noted (Fig. 3a). Chest CT was performed to
evaluate the further development of abnormal lesions.
We found that osteomyelitis of the ribs had developed
following the formation of the skin ulcer compared with
the previous CT. A rib defect was observed on three-
dimensional chest CT (Fig. 3b). The rib defect was man-
aged conservatively because the patient’s symptoms were
limited to left chest pain in her daily life.
Discussion
Acute- and late-onset skin reactions are adverse effects
of radiation therapy and are categorized using several
25 sessions at 3 months 56 sessions at 6 months 67 sessions at 8 months
A B C
86 sessions at 11 months
D
Fig. 2 Representative gross appearance of the affected skin during hyperbaric oxygen therapy. a Massive pus discharge (arrow) was observed
after 25 sessions. b–d Pus discharge and fistula size gradually decreased over time (arrows)
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Fig. 1 Gross appearance of the affected area and computed tomographic images of the left chest wall at the first visit. a A skin ulcer with
redness and pus discharge was observed. b Computed tomographic images showing that the fistula did not connect into the thorax (arrows)
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scoring systems [6, 7]. Delayed changes usually develop
within 4–6 months, and the irradiated skin could have
an increased risk of infection, delayed healing, wound
dehiscence, fistula formation, and wound necrosis [8].
Radiation-induced skin ulcers can become intractable as
a result of improper wound healing, infection, or both.
In our patient, thinning of the chest wall by resection of
breast muscle and the irradiation protocol contributed
to the formation of an intractable ulcer. According to
the patient’s history of dermatitis during radiation ther-
apy, the skin ulcer recurred 25 years after treatment.
The patient’s skin was already red and fragile, and the
ulcer had become intractable, but the infection was
localized around the ulcer before her hospital visit. For
these reasons, HBO2 was considered to be the best con-
servative treatment option. In the case of large skin
ulcers with massive infection and bone necrosis, surgical
treatment, including resection of the ulcer, sternum, and
ribs with osteomyelitis followed by reconstruction of the
chest wall using skin or muscle flaps, should be consid-
ered [9, 10]. Malignancy also should be considered in
the differential diagnosis, and a biopsy should be per-
formed to rule out a second malignancy in the radiated
field [11]. In our patient, carcinogenesis was not sus-
pected on the basis of the gross appearance of the skin
and radiographic findings before starting HBO2. We ex-
amined the appearance of the skin at least every 2 weeks
during the HBO2 sessions to detect nontypical wound
healing.
HBO2 involves breathing pure oxygen at an ambient
pressure higher than atmospheric pressure. The
worldwide standard HBO2 protocol is to apply 2.0–
2.8 ATA for 60–90 minutes with pressurized air or
oxygen inside the chamber [12]. HBO2 is thought to
have complex effects on immunity, oxygen transport,
and hemodynamics, resulting in favorable therapeutic
effects by reducing hypoxia and edema as well as en-
abling normal host responses to infection and ische-
mia [12, 13]. Indications for HBO2 according to the
Undersea and Hyperbaric Medical Society include
arterial insufficiency (enhancement of healing for se-
lect problematic wounds); refractory osteomyelitis;
and delayed, radiation-induced soft tissue injury or
bone necrosis [14]. There are several contraindica-
tions for HBO2. Absolute contraindications include
doxorubicin treatment (because of cardiac toxicity),
mafenide acetate treatment (because of central vaso-
constriction), and untreated pneumothorax [15].
According to authors of a Cochrane review of chronic
wounds, HBO2 improved healing in the short term
but not with long-term follow-up [16]. In experimen-
tal studies, HBO2 treatment led to proliferation of
bovine aortic endothelial cells and human skin fibro-
blasts in vitro as well as accelerated wound epithelial-
ization and neovascularization in mouse ears [17, 18].
Clinically, a positive correlation has been reported
between tissue oxygenation and various markers of
wound healing. These results support the efficacy of
HBO2 [19].
Our patient’s case met the indications for HBO2, and
she had no recurrence at least 6 months after treatment.
The average total number of HBO2 sessions for chronic
A B
 101 sessions 6 months after the HBO2 
Fig. 3 Gross appearance of the affected area and three-dimensional computed tomographic image of the left chest wall 6 months after
starting hyperbaric oxygen therapy (HBO2). a The fistula completely disappeared. b Three-dimensional computed tomographic image
showing a rib defect (arrows)
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wounds is in the range of 30–40 [20]. Our patient under-
went 101 sessions over a period of 1 year. However, cases
of radiation-induced injury require a greater number of
sessions (30–60) than those involving chronic wounds [5].
In particular, radiation-induced ulcers of the chest wall
with bone necrosis often require more frequent HBO2
sessions as well as surgical intervention [20]. In one case
report, necrotic lesions induced by accidental radiation ex-
posure improved after 140 sessions of HBO2, without any
adverse effects [21]. Thus, delayed, radiation-induced in-
jury of the chest wall can be treated successfully with
more than 100 sessions of HBO2. However, long-term
studies are needed to determine whether surgical inter-
vention will eventually be required.
Conclusions
We treated a patient with refractory skin ulcer on the left
chest wall that developed 25 years after radical mastec-
tomy and radiation therapy for breast cancer. The patient
was successfully treated with HBO2 a total of 101 times
over the course of 1 year without any adverse effects.
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